The effects of B cell depletion on immune related adverse events associated with immune checkpoint inhibition | Experimental Hematology & Oncology | Full Text

The effects of B cell depletion on immune related adverse events associated with immune checkpoint inhibition | Experimental Hematology & Oncology | Full Text

The effects of B cell depletion on immune related adverse events associated with immune checkpoint inhibition

This letter describes the potential effect of B cell depletion on immune related adverse events associated with immune checkpoint inhibition. B cell depleting agents such as rituximab reduce B cell to plasma c...

Authors:Rasmus Strøm Risbjerg, Mie Vennize Hansen, Anne Sofie Sørensen and Tue Wenzel Kragstrup

Citation:Experimental Hematology & Oncology 2020 9:9

Content type:Letter to the Editor

 

Published on: 25 May 2020

• ViewFull Text
 
• ViewPDF